{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T07:33:48Z","timestamp":1722929628253},"reference-count":48,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T00:00:00Z","timestamp":1390003200000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The first Japanese edition of guidelines for management of cutaneous lymphoma was published jointly in 2009 by the Japanese Dermatological Association (<jats:styled-content style=\"fixed-case\">JDA<\/jats:styled-content>) and the Japanese Skin Cancer Society (<jats:styled-content style=\"fixed-case\">JSCS<\/jats:styled-content>) \u2013 Lymphoma Study Group; the guidelines were revised in 2011, and published in English in 2013. The <jats:styled-content style=\"fixed-case\">JDA<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">JSCS<\/jats:styled-content> guidelines are unique because they describe information and management practices for lymphomas specific to Asia, such as adult <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell leukemia\/lymphoma and extranodal natural killer\/<jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell lymphoma, nasal type. In the present article, we have highlighted the essential points of management for cutaneous lymphomas in Asia. In order to complement the guidelines, we have added further information and our clinical experience of some currently available agents for cutaneous lymphomas in Japan.<\/jats:p>","DOI":"10.1111\/1346-8138.12346","type":"journal-article","created":{"date-parts":[[2014,1,18]],"date-time":"2014-01-18T13:16:47Z","timestamp":1390051007000},"page":"43-49","source":"Crossref","is-referenced-by-count":8,"title":["Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association\/Japanese Skin Cancer Society guidelines"],"prefix":"10.1111","volume":"41","author":[{"given":"Keiji","family":"Iwatsuki","sequence":"first","affiliation":[{"name":"Departments of Dermatology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Hamada","sequence":"additional","affiliation":[{"name":"Departments of Dermatology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Japanese Skin Cancer Society \u2013 Lymphoma Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,1,18]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12299"},{"key":"e_1_2_9_3_1","first-page":"1703","article-title":"Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification","volume":"90","author":"Lee MY","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12308-012-0169-1"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.4132\/KoreanJPathol.2011.45.3.254"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-6-77"},{"key":"e_1_2_9_8_1","first-page":"1189","article-title":"Guidelines for the management of cutaneous malignant tumors II: cutaneous lymphomas","volume":"119","author":"Iwatsuki K","year":"2009","journal-title":"Jap J Dermatol"},{"key":"e_1_2_9_9_1","first-page":"1513","article-title":"Guidelines for the management of cutaneous lymphomas (2011)","volume":"122","author":"Sugaya M","year":"2012","journal-title":"Jap J Dermatol"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01639.x"},{"key":"e_1_2_9_11_1","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon\u20102a plus acitretin versus interferon\u20102a plus PUVA in patients with cutaneous T\u2010cell lymphoma stages I and II","volume":"92","author":"Stadler R","year":"1998","journal-title":"Blood"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.1200\/jco.2006.24.18_suppl.7541","article-title":"Prospective, randomized, multicentre clinical trial on the use of interferon a 2a plus PUVA versus PUVA monotehrapy in patients with cutaneous T\u2010cell lymphoma, stage I and II","volume":"24","author":"Stadler R","year":"2006","journal-title":"J Clin Oncol"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912283212603"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01525.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2386"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-231548"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2434"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2012.01554.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"S\u00e9zary syndrome T\u2010cell clones display T\u2010helper 2 cytokines and express the accessory factor\u20101 (interferon\u2010gamma receptor beta\u2010chain)","volume":"88","author":"Dummer R","year":"1996","journal-title":"Blood"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.132"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08187.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.08.006"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12341"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.5227\/skincancer.8.352"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.0630"},{"key":"e_1_2_9_26_1","first-page":"581","article-title":"Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early\u2010stage cutaneous T\u2010cell lymphoma","volume":"137","author":"Duvic M","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07975.x"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.11.058"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.325"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01475-0"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09230.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2006.n.039"},{"key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1200\/JCO.2000.18.13.2603","article-title":"Gemcitabine treatment in pretreated cutaneous T\u2010cell lymphoma: experience in 44 patients","volume":"13","author":"Zinzani PL","year":"2000","journal-title":"J Clin Oncol"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21449"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12875523"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07740.x"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.8972"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"key":"e_1_2_9_40_1","first-page":"277","article-title":"Ethnoepidemiologicay of ATL\/HTLV in Mongoloids with special reference to Mongoloid dispersal","volume":"50","author":"Tajima K","year":"2003","journal-title":"Gann Monogr Cancer Res"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/101754"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3472"},{"key":"e_1_2_9_44_1","doi-asserted-by":"crossref","unstructured":"DuvicM Pinter\u2010BrownL FossFMet\u00a0al.Results of a phase 1\/2 study for KW\u20100761 a monoclonal antibody directed against CC chemokine receptor type 4 (CCR4) in CTCL patients. ASH Annual Meeting Abstracts 2010 116: abstract 962 Clincal trials. Gov: NCT00888927) Orlando USA 2010.","DOI":"10.1182\/blood.V116.21.962.962"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12322"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6287"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.122"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152850"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.011"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1346-8138.12346","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1346-8138.12346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:45:29Z","timestamp":1694511929000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1346-8138.12346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/1346-8138.12346"],"URL":"https:\/\/doi.org\/10.1111\/1346-8138.12346","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"type":"print","value":"0385-2407"},{"type":"electronic","value":"1346-8138"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}